In this randomised , parallel-group , comparator-controlled , single-blind phase 3 trial , we assessed the efficacy of a new fluid protocol based on the left ventricular end-diastolic pressure for the prevention of contrast-induced acute kidney injury in patients undergoing cardiac catheterisation .